Stay updated on IBI310 Combo vs Sorafenib in HCC Clinical Trial

Sign up to get notified when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IBI310 Combo vs Sorafenib in HCC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T13:17:19.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH website updates and says the agency is transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.8%
    Check dated 2026-10-24T12:54:49.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The site footer now identifies the release as v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T13:18:21.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1, with no apparent change to the study record.
    Difference
    0.1%
    Check dated 2026-10-10T12:51:29.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The record history now reflects a new revision entry v3.7.0 and the removal of the older v3.6.6 entry, indicating an update to the study record’s version history.
    Difference
    0.1%
    Check dated 2026-09-19T22:03:35.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry v3.6.6 and removes the previous v3.6.5, reflecting an update to the official history log.
    Difference
    0.1%
    Check dated 2026-08-29T19:29:02.000Z thumbnail image

Stay in the know with updates to IBI310 Combo vs Sorafenib in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.